Pharmaceuticals

Trulicity Market 2026 accelerating with growing global diabetic population

March 27, 2026March 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Trulicity Market By The End Of 2030?

The trulicity market size has expanded significantly in recent years. It is anticipated to grow from $7.98 million in 2025 to $8.7 million in 2026, exhibiting a compound annual growth rate (CAGR) of 9.0%. The upward trend observed historically can be credited to the increasing prevalence of type 2 diabetes, the constraints of oral antidiabetics, the demonstrated effectiveness of glp-1 therapies, ongoing physician prescribing trends, and difficulties concerning patient adherence.

The trulicity market size is anticipated to demonstrate substantial expansion over the next few years, projected to attain $12.15 million by 2030 at a compound annual growth rate (CAGR) of 8.7%. This expansion during the forecast period can be attributed to factors such as the increasing incidence of obesity-related diabetes, broadening GLP-1 indications, enhanced reimbursement access, a rising burden of lifestyle diseases, and more widespread primary care adoption. Significant trends foreseen in this period include the growing uptake of GLP-1 receptor agonists, a transition towards once-weekly diabetes therapies, the integration of weight management within diabetes care, an expanded emphasis on cardiovascular risk reduction, and increasing patient preference for the convenience of injectable medications.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19941&type=smp

What Drivers Are Shaping The Future Growth Of The Trulicity Market?

The expanding diabetes patient base is anticipated to drive the trulicity market forward. Diabetes, a chronic health condition, is characterized by elevated blood sugar levels stemming from the body’s inability to produce insulin effectively or use it properly. If not properly managed, it can lead to serious complications. This rise in the diabetes population is attributed to factors such as urbanization, unhealthy eating patterns, physical inactivity, and genetic predisposition. The growing number of individuals with diabetes consequently increases the demand for effective treatments like trulicity, which assists in managing blood sugar levels and improving patient outcomes. For instance, in March 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, the percentage of people with type 1 diabetes in England receiving 8 care processes at GP practices participating in the NDA rose to 43.8% in March 2023, up from 35.2% in 2022. Therefore, the increasing diabetes population is a key driver for the growth of the trulicity market.

Which Segment Classifications Shape The Trulicity Market?

The trulicity market covered in this report is segmented –

1) By Type: Prefilled Syringe Package, Vial Package

2) By Application: Type 2 Diabetes Management, Glycemic Control, Weight Management, Cardiovascular Risk Reduction

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

How Are Trends Impacting The Trulicity Market?

Major companies in the trulicity market are adopting strategic investment approaches, such as biologics production facilities, to secure a competitive advantage and meet escalating demand. Biologics production facilities are specialized manufacturing sites for biologic drugs, complex therapies derived from living organisms, including monoclonal antibodies, vaccines, and cell and gene therapies. For instance, in January 2023, Eli Lilly and Company, a US-based pharmaceutical company, invested $450 million to expand its North Carolina manufacturing plant, enhancing the production of its diabetes drug Trulicity. This contributes to a $1.7 billion investment in the facility, expected to start production later this year, with full completion by 2027, creating 100 additional jobs. Furthermore, Lilly is establishing two new facilities in Indiana and allocating €400 million for biologics production in Ireland. Overall, the company intends to invest $2.5 billion in manufacturing capacity in the coming years to support increasing demand and new product launches.

Which Companies Are Expanding Their Footprint In The Trulicity Market?

Major companies operating in the trulicity market are Eli Lilly And Company, Novo Nordisk

Read the full trulicity market report here:

https://www.thebusinessresearchcompany.com/report/trulicity-global-market-report

Which Geographic Regions Are Influencing Demand In The Trulicity Market?

North America was the largest region in the trulicity market in 2025. The regions covered in the trulicity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Trulicity Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19941&type=smp

Browse Through More Reports Similar to the Global Trulicity Market 2026, By The Business Research Company

Trocars Market Report 2026

https://www.thebusinessresearchcompany.com/report/trocars-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Membrane Filtration Market Report 2026

https://www.thebusinessresearchcompany.com/report/membrane-filtration-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795